Ronald Long, MD
Pain Medicine · Goldsboro, NCNPI 1013971654
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,282 of the $8,170 with a category attached, or 76.9%. 27 manufacturers reported payments, led by Relievant Medsystems, Inc. at 38.9% of the total. Reporting peaked in 2023 at $3,954 and has fallen 85.6% since, to $570 in 2025.
Across 286 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$3K
- Abbott$2K
- SPR Therapeutics, Inc$430
- Boston Scientific$345
- Collegium Pharmaceutical, Inc.$266
- Medtronic$205
- plus $1K from 21 others
What the payments were for
- Travel & lodging$1,88923%
- Food & beverage$6,28277%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 26 | $3,177 |
| Abbott | 162 | $2,500 |
| SPR Therapeutics, Inc | 5 | $430 |
| Boston Scientific | 4 | $345 |
| Collegium Pharmaceutical, Inc. | 14 | $266 |
| Medtronic | 7 | $205 |
| AbbVie | 8 | $192 |
| Valinor Pharma, LLC | 7 | $136 |
| Scilex Pharmaceuticals Inc. | 5 | $101 |
| Pfizer | 6 | $88 |
| Biodelivery Sciences International, Inc. | 7 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Virtus Pharmaceuticals LLC | 4 | $80 |
| Arbor Pharmaceuticals, Inc. | 5 | $68 |
| Sanofi-aventis U.S. LLC | 3 | $61 |
| Vertos Medical, Inc. | 3 | $53 |
| Si-bone, Inc. | 2 | $52 |
| Redhill Biopharma Inc. | 2 | $46 |
| Almatica Pharma LLC | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Vertex | 1 | $31 |
| Averitas Pharma Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Zimmer Biomet | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$10,245
- SPRINT PNS System$348
How this compares
$8,170 in reported general payments places this provider in the 70th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 34 | $452 |
| Tramadol Hcl | 28 | $230 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $216 |
| Meloxicam | 12 | $37 |
| Diazepam | 22 | $20 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Goldsboro
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.